TRPM2通道:在黑色素瘤中潜在的治疗目标?
Hattie M Foster1, McKenzie N Carle1, Lukas R Jira1
1Department of Pharmaceutical & Biomedical Sciences, Ohio Northern University, Ada, OH 45810, USA.
International journal of molecular sciences
|July 14, 2023
概括
暂时受体潜在的 Melastatin (TRPM) 通道在黑色素瘤中很重要. TRPM2显示了治疗潜力,对抗性为黑色素瘤患者提供了未来的治疗选择.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 皮肤病学 皮肤病学
背景情况:
- 短暂受体潜在拉斯 (TRPM) 子家族,有八个成员,与黑色素瘤有关.
- 几位TRPM成员在皮肤癌进展,生长和患者预后方面发挥着作用.
- 由于其在黑色素瘤治疗中的潜力,TRPM2特别感兴趣.
研究的目的:
- 研究TRPM2在黑色素瘤中的作用.
- 探索TRPM2作为黑色素瘤的治疗点.
主要方法:
- 对以前和最近关于TRPM2表达和黑色素瘤功能的研究进行了综述.
- 对TRPM2在黑色素瘤生长,扩散和存活中的作用的分析.
主要成果:
- 在黑色素瘤中观察到TRPM2表达水平的增加.
- 在黑色素瘤细胞生长,增殖和生存中,TRPM2起着重要的作用.
结论:
- TRPM2是黑色素瘤的新兴治疗点.
- 对抗TRPM2可能为黑色素瘤患者提供一种新的治疗策略.
相关概念视频
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Enzyme-linked Receptors
78.8K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
78.8K


